Prostate Cancer UK

Recent papers from Prostate Cancer UK

1. Trends in bone health agent use and skeletal events in metastatic castration-resistant prostate cancerJNCI Journal of the National Cancer Institute · 2026
2. An evaluation of the self-removal of catheters post-prostatectomy at Royal Surrey HospitalBMC Urology · 2026
3. Safety Profile of Apalutamide in Prostate Cancer: A Pooled Analysis of Phase III Trials and the Under-Recognized Need for Real-World Thyroid MonitoringProstate International · 2026
4. Xanthogranulomatous prostatitis mimicking prostate carcinoma: a case report and comprehensive literature reviewFrontiers in Medicine · 2026
5. APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer TrialJCO Precision Oncology · 2026
6. Concurrent cognitive and physical training for cognition in men with prostate cancer: a study protocol for a pilot randomized controlled trialFrontiers in Medicine · 2026
7. Paediatric therapeutic development workshop on medulloblastomaBritish Journal of Cancer · 2026
8. Opportunities to enhance cancer research through advocate-researcher partnershipsCancer Research · 2026
9. Paediatric Therapeutic Development Workshop on rhabdomyosarcomaBritish Journal of Cancer · 2026
10. Efficacy and safety of enzalutamide (ENZA) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) and cardiometabolic comorbidities (CMDs) and/or related concomitant medications (meds): ARCHES post hoc.Journal of Clinical Oncology · 2026
11. Predictors of treatment (tx) duration in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) treated with enzalutamide (ENZA): A post hoc analysis of ARCHES.Journal of Clinical Oncology · 2026
12. Real-world cost effectiveness of androgen receptor pathway inhibitors for metastatic hormone sensitive prostate cancer: An economic evaluation utilizing data from the International Registry for Men with Advanced Prostate Cancer (IRONMAN).Journal of Clinical Oncology · 2026
13. The Role of Surgical Margins as Outcome Metrics in a Quality Assurance Program for Robot-Assisted Radical ProstatectomyInternational Journal for Quality in Health Care · 2026
14. Shared decision-making in prostate cancer treatment: selecting an androgen deprivation therapy optionFuture Oncology · 2026
15. Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer ManagementMolecular Pharmaceutics · 2026
16. Consensus Recommendations for Disease- and Treatment-Related Fatigue in Patients With Advanced Prostate Cancer: A Modified Delphi PanelJournal of the National Comprehensive Cancer Network · 2026
17. Malignant upper urinary tract obstruction resulting in hospital admission: a qualitative study of patient, carer and clinician experiences and information receivedBMJ Open · 2026
18. Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspectiveBMJ Oncology · 2026
19. Active surveillance in the elderly: Is it the right strategy to avoid overtreatment?BJU International · 2026
20. Impact of Radiotherapy and Hormone Therapy in Bone Health in Prostate Cancer: Molecular Mechanisms, Clinical Evidence, and Future DirectionsPrecision Oncology · 2026